Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Venetoclax Combine Azacitidine for Acute Myeloid Leukemia in China: A Real-World Single-Center Study

Jiefei Bai, Hui Liu, Jiangtao Li, Ting Wang, Chunli Zhang, Yazi Yang, Xiaoya Yun, Jingjing Yin, Long Qian, Fei Zhao, Ru Feng, Hongmei Jing

Blood (2024) 144 (Supplement 1): 7896.

https://doi.org/10.1182/blood-2024-193714

Published: 2024

Journal Articles

A Predictive Model Combining Clinical Characteristics and Nutritional Risk Factors for Overall Survival after Umbilical Cord Blood Transplantation

Meijuan Tu, Aijie Huang, Lijuan Ning, Baolin Tang, Chunli Zhang, Guangyu Sun, Xiang Wan, Kaidi Song, Wen Yao, Ping Qiang, Yue Wu, Xiaoyu Zhu

Blood (2023) 142 (Supplement 1): 7097.

https://doi.org/10.1182/blood-2023-180705

Published: 2023

Journal Articles

Phase I Study of a BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <3 Days Using the High-Performance Platform

Hui Liu, Ting Wang, Yazi Yang, Ru Feng, Jiangtao Li, Chunli Zhang, Jiefei Bai, Yanping Ding, Guanghua Liu, Fei Wu, Xinan Lu, Jian Li, Ting He

Blood (2022) 140 (Supplement 1): 10307–10308.

https://doi.org/10.1182/blood-2022-166011

Published: 2022

Journal Articles

Zanubrutinib Plus Rituximab for the Treatment of Elderly Unfit Patients with Previously Untreated Diffuse Large-B Cell Lymphoma

Jiefei Bai, Jiangtao Li, Ru Feng, Long Qian, Jingjing Yin, Shuai Zhang, Ting Wang, Yazi Yang, Chunli Zhang, Jian Li, Hui Liu

Blood (2022) 140 (Supplement 1): 3748–3749.

https://doi.org/10.1182/blood-2022-168597

Published: 2022

Journal Articles

A Clinical Study On Rituximab for Probable and Proven EBV Disease Post Haematopoietic Stem-Cell Transplantation

Lanping Xu, Daihong Liu, Kaiyan Liu, MD, Chunli Zhang, Fengrong Wang, Jingzhi Wang, Yu Wang, MD, Huan Chen, Yuanyuan Zhang, Chenhua Yan, Wei Han, MD, Yuhong Chen, MD, PhD, Ting Zhao, Xiao-Hui Zhang, Xiaojun Huang

Blood (2012) 120 (21): 4512.

https://doi.org/10.1182/blood.V120.21.4512.4512

Published: 2012

NARROW

Efficacy and Safety of Venetoclax Combine Azacitidine for Acute Myeloid Leukemia in China: A Real-World Single-Center Study

A Predictive Model Combining Clinical Characteristics and Nutritional Risk Factors for Overall Survival after Umbilical Cord Blood Transplantation

Phase I Study of a BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <3 Days Using the High-Performance Platform

Zanubrutinib Plus Rituximab for the Treatment of Elderly Unfit Patients with Previously Untreated Diffuse Large-B Cell Lymphoma

A Clinical Study On Rituximab for Probable and Proven EBV Disease Post Haematopoietic Stem-Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Efficacy and Safety of Venetoclax Combine Azacitidine for Acute Myeloid Leukemia in China: A Real-World Single-Center Study

A Predictive Model Combining Clinical Characteristics and Nutritional Risk Factors for Overall Survival after Umbilical Cord Blood Transplantation

Phase I Study of a BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <3 Days Using the High-Performance Platform

Zanubrutinib Plus Rituximab for the Treatment of Elderly Unfit Patients with Previously Untreated Diffuse Large-B Cell Lymphoma

A Clinical Study On Rituximab for Probable and Proven EBV Disease Post Haematopoietic Stem-Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only